Progesterone is one of the most clinically significant female hormones, and one of the least tested outside fertility clinics. Most women I've spoken to have had their thyroid checked, their iron checked, maybe their testosterone. Very few have had their progesterone measured.

Yet it's the hormone that confirms ovulation, supports early pregnancy, regulates the menstrual cycle, influences mood and sleep, and is the first to decline as perimenopause approaches. If you're investigating cycle irregularity, fertility concerns, or hormonal symptoms, progesterone deserves a spot on the panel.

A note before we get into it

What progesterone actually does

Progesterone is often called the "pregnancy hormone" because its most visible role is supporting the uterine lining for embryo implantation and sustaining early pregnancy. But it does far more than that.

Menstrual cycle regulation. After ovulation, the corpus luteum (the structure left behind after the egg is released) produces progesterone. This transforms the uterine lining from a proliferative state, driven by oestrogen in the first half of the cycle, to a secretory state. It stabilises the lining and prepares it for potential implantation. If pregnancy doesn't occur, progesterone drops, the lining sheds, and menstruation begins. Without adequate progesterone, cycles can become irregular, heavy, or prolonged.

Endometrial protection. Oestrogen stimulates endometrial growth. Progesterone counterbalances that stimulation. Without progesterone (in anovulatory cycles, for example), oestrogen acts unopposed on the endometrium, increasing the long-term risk of endometrial hyperplasia. This is why progesterone or progestins are included in HRT for women with a uterus.

Mood and neurological function. Progesterone is metabolised to allopregnanolone, a neurosteroid that acts on GABA receptors (the brain's primary calming neurotransmitter system). Adequate progesterone supports mood stability, may reduce anxiety, and promotes sleep. The premenstrual mood drop many women experience coincides with falling progesterone in the late luteal phase.

Sleep. Through its GABA-ergic effects, progesterone promotes sleep onset and quality. Women often report better sleep in the luteal phase (when progesterone is high) and worse sleep premenstrually and during perimenopause (when progesterone drops).

Bone health. Progesterone stimulates osteoblast activity (bone-building cells), working alongside oestrogen to maintain bone density. Its decline in perimenopause may contribute to accelerated bone loss.

Immune modulation. Progesterone modulates immune function during pregnancy and throughout the cycle, influencing susceptibility to infections and autoimmune flares.

The cycle timing problem

This is the single most important thing to understand about progesterone testing: the timing of your blood draw determines whether the result is interpretable.

Progesterone is low in the first half of the menstrual cycle (follicular phase). It surges after ovulation and peaks roughly 7 days later (mid-luteal phase). Then it drops before menstruation.

If you test progesterone on Day 5 of your cycle, it will be low. That's normal, not a deficiency.

If you test on Day 21 of a 28-day cycle (or 7 days after confirmed ovulation), progesterone should be elevated if ovulation occurred. This is the clinically meaningful window.

The problem with irregular cycles. Day 21 testing assumes a 28-day cycle with ovulation on Day 14. If your cycles are longer or irregular (common in PCOS), Day 21 might be too early. You may not have ovulated yet. In these cases, testing should be timed to 7 days after suspected ovulation, tracked via basal body temperature, ovulation predictor kits, or clinical assessment.

Testing at the wrong time is worse than not testing at all. A low result from bad timing can be misinterpreted as a deficiency or anovulation when neither is actually the case.

Progesterone and fertility

Confirming ovulation. A mid-luteal progesterone above 25 nmol/L (some labs use 30 nmol/L) confirms that ovulation occurred. This is one of the most basic and important fertility investigations. If you're not ovulating, you can't conceive, and progesterone is the confirmation test.

Luteal phase defect. If progesterone rises after ovulation but not sufficiently, or if the luteal phase (the time between ovulation and menstruation) is too short (less than 10 days), the uterine lining may not be adequately prepared for implantation. This is called a luteal phase defect and is a recognised contributor to infertility and early pregnancy loss.

Recurrent miscarriage. Low progesterone in early pregnancy has been investigated as a contributor to recurrent miscarriage. Some clinicians offer progesterone supplementation in early pregnancy for women with a history of recurrent loss, though the evidence is still evolving.

For broader fertility context: Fertility Blood Tests

Progesterone and PCOS

PCOS and progesterone have a specific relationship. In PCOS, chronic anovulation is common. The follicle develops but doesn't reliably release an egg. Without ovulation, the corpus luteum doesn't form, and progesterone isn't produced in the second half of the cycle.

Consequences of chronic anovulation:

No luteal progesterone surge means irregular or absent periods. Unopposed oestrogen leads to heavier bleeding when periods do occur, plus increased long-term endometrial risk. Without progesterone-mediated GABA effects, premenstrual anxiety, mood instability, and poor sleep may follow. And without the ability to confirm ovulation, fertility challenges arise.

Progesterone testing in PCOS serves two purposes: confirming whether ovulation is occurring in a given cycle, and monitoring the response to ovulation-inducing treatments (letrozole, clomiphene).

Detailed PCOS coverage: PCOS Blood Tests

Progesterone in perimenopause

One of the least discussed aspects of the menopausal transition is that progesterone declines before oestrogen.

In the early stages of perimenopause, cycles may still appear regular, but ovulation becomes less consistent. When you don't ovulate, you don't produce progesterone. So the hormonal environment shifts to relative oestrogen dominance: oestrogen still fluctuating (sometimes very high), but progesterone increasingly absent.

Symptoms of the progesterone-first decline:

Heavier, more frequent, or more prolonged periods. Increased PMS-type symptoms including bloating, breast tenderness, and mood instability. Sleep disruption from the loss of the GABA-ergic calming effect. Anxiety that feels hormonal, worsening in the luteal phase or appearing randomly through the month. Spotting or irregular bleeding.

These symptoms often precede the classic hot flushes and night sweats by years. Many women experience them in their early-to-mid forties and attribute them to stress. They're frequently hormonal.

Detailed menopause coverage: Menopause Blood Tests

Progesterone and mood, sleep, and anxiety

This section deserves particular emphasis because it's the most underrecognised clinical application of progesterone.

The connection between progesterone and mental health runs through allopregnanolone, the neurosteroid metabolite that modulates GABA-A receptors. When progesterone is adequate, allopregnanolone provides a calming, anxiolytic effect. When progesterone drops (premenstrually, in anovulatory cycles, or in perimenopause), that calming influence withdraws.

Premenstrual mood symptoms (PMS/PMDD). The luteal phase drop in progesterone, and consequently allopregnanolone, is central to premenstrual mood disturbance. For most women, this is mild. For women with PMDD (premenstrual dysphoric disorder), the withdrawal can be severe and disabling.

Perimenopausal anxiety. Women who develop new-onset anxiety in their forties, particularly if it's cyclical or coincides with sleep disruption and menstrual changes, may be experiencing the neurological consequences of declining progesterone rather than a primary anxiety disorder.

Sleep quality. As covered in the sleep article, progesterone's GABA-ergic action promotes sleep. Its decline contributes to the insomnia and sleep fragmentation that many women experience in perimenopause.

Progesterone testing doesn't diagnose mood disorders. But in the right clinical context, a low mid-luteal progesterone adds a physiological explanation to psychological symptoms and opens management options that wouldn't be considered if the only framework is "stress" or "anxiety."

How the test works

Standard blood test. Serum progesterone measured from a venous blood draw. No special preparation beyond timing.

When to test. Day 21 of a 28-day cycle, or 7 days after confirmed or suspected ovulation. If cycles are irregular, discuss timing with your clinician. Testing at the wrong time produces uninterpretable results.

Fasting. Not required.

Time of day. Morning is preferred for consistency, though progesterone doesn't have a strong circadian variation.

Understanding your result

Mid-luteal progesterone (Day 21 / 7 days post-ovulation)

Above 25-30 nmol/L: Confirms ovulation occurred. Adequate luteal phase support.

16-25 nmol/L: Grey zone. May indicate ovulation occurred but with suboptimal progesterone production. Clinical context and symptoms guide interpretation.

Below 16 nmol/L (tested at correct timing): Suggests anovulation or luteal phase insufficiency. Warrants further investigation if fertility is a concern.

Below 5 nmol/L: Consistent with no ovulation in that cycle.

Follicular phase progesterone (early cycle)

Should be low (below 5 nmol/L). This is normal. Progesterone isn't produced until after ovulation.

Early pregnancy

Progesterone rises progressively. Levels vary widely but are generally above 25 nmol/L in viable early pregnancy. Interpretation in pregnancy requires obstetric context.

A single low result doesn't diagnose a condition. Progesterone varies cycle to cycle. Repeat testing over 2-3 cycles provides a more reliable picture.

Tests to consider through Bloody Good

Comprehensive coverage. The Bloody Good Test covers 100 biomarkers including thyroid, iron, vitamin D, cholesterol, liver, and more. Pairing this with targeted hormonal tests (progesterone, oestradiol, FSH/LH) on the correct cycle day provides the most thorough assessment.

What to do after testing

Explore more biomarkers

Browse the Bloody Good Biomarker Directory